Paxlovid for the treatment of severe or critical COVID-19 in children
Linjuan Xiang, Qun Wang, Yanwen Xu, Tong Yu et autres
Abstract Background Paxlovid, known for its efficacy against SARS-CoV-2, is currently limited in its use for treating pediatric COVID-19, particularly in severe or critical cases. Methods We conducted a study within a single-center, prospective cohort of 450 children diagnosed with COVID-19 between …
cn (code pays fourni par la source)